Search Results

Filter
  • 1-10 of  11 results for ""ALZHEIMER'S patients""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities.

  • Authors : Meguro K; Division of Geriatric Behavioral Neurology, CYRIC, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. .; Ouchi Y

Subjects: Activities of Daily Living* ; Nursing Homes*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy

  • Source: BMC neurology [BMC Neurol] 2014 Dec 17; Vol. 14, pp. 243. Date of Electronic Publication: 2014 Dec 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

Record details

×
Editorial & Opinion

Measures to prevent Alzheimer's patients from discontinuing the use of cholinesterase inhibitors.

  • Authors : Meguro K; Division of Geriatric Behavioral Neurology, CYRIC, Tohoku University, Sendai, Japan.

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use ; Indans/Indans/Indans/*therapeutic use

  • Source: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2014 Sep; Vol. 14 (3), pp. 210-1. Date of Electronic Publication: 2014 Sep 14.Publisher: Blackwell Pub Country of Publication: England NLM ID: 101230058 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use ; Indans/Indans/Indans/*therapeutic use

  • Source: Current medical research and opinion [Curr Med Res Opin] 2006 Jan; Vol. 22 (1), pp. 49-59.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print Cited Medium: Print ISSN: 0300-7995

Record details

×
Academic Journal

Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.

  • Authors : Nobili F; Clinical Neurophysiology Service, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6 I-16132 Genoa, Italy. ; Vitali P

Subjects: Tomography, Emission-Computed, Single-Photon*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*physiopathology

  • Source: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology [Clin Neurophysiol] 2002 Aug; Vol. 113 (8), pp. 1241-8.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100883319 Publication Model: Print Cited Medium: Print ISSN: 1388-2457 (Print)

Record details

×
Academic Journal

Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice.

Subjects: Amino Acids/Amino Acids/Amino Acids/*pharmacology ; Indans/Indans/Indans/*pharmacology ; Neuronal Plasticity/Neuronal Plasticity/Neuronal Plasticity/*drug effects

  • Source: Synapse (New York, N.Y.) [Synapse] 2012 Nov; Vol. 66 (11), pp. 938-49. Date of Electronic Publication: 2012 Aug 13.Publisher: Country of Publication: United States NLM ID: 8806914 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2396

Record details

×
Academic Journal

[Donepezil-induced neuroprotection of acetylcholinergic neurons in olfactory bulbectomized mice].

  • Authors : Yamamoto Y; Department of Pharmacology, Tohoku University, Sendai, Japan.; Shioda N

Subjects: Neuroprotective Agents*; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*pharmacology ; Indans/Indans/Indans/*pharmacology

  • Source: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 2010 May; Vol. 130 (5), pp. 717-21.Publisher: Nihon Yakugakkai Country of Publication: Japan NLM ID: 0413613 Publication Model: Print Cited Medium: Print ISSN: 0031-6903 (Print)

Record details

×
Academic Journal

Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Subjects: Phenylcarbamates* ; Treatment Outcome*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy

  • Source: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2002 Summer; Vol. 18 (3), pp. 497-507.Publisher: Cambridge University Press Country of Publication: England NLM ID: 8508113 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease.

  • Authors : Hanyu H; Department of Geriatric Medicine, Tokyo Medical University, Tokyo 160-0023, Japan. ; Tanaka Y

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*pathology ; Atrophy/Atrophy/Atrophy/*pathology ; Cholinergic Fibers/Cholinergic Fibers/Cholinergic Fibers/*pathology

  • Source: Neuroscience letters [Neurosci Lett] 2002 Feb 08; Vol. 319 (1), pp. 33-6.Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.

  • Authors : Sugimoto H; Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan.; Yamanishi Y

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Cholinesterase Inhibitors/Cholinesterase Inhibitors/Cholinesterase Inhibitors/*therapeutic use ; Indans/Indans/Indans/*therapeutic use

  • Source: Current medicinal chemistry [Curr Med Chem] 2000 Mar; Vol. 7 (3), pp. 303-39.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

[Discovery and development of donepezil hydrochloride for the treatment of Alzheimer's disease].

  • Authors : Sugimoto H; Tsukuba Research Laboratories for Drug Discovery, Eisai Co., Ltd., Ibaraki, Japan.; Yamanishi Y

Subjects: Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/chemical synthesis ; Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/pharmacology ; Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/therapeutic use

  • Source: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 1999 Feb; Vol. 119 (2), pp. 101-13.Publisher: Nihon Yakugakkai Country of Publication: Japan NLM ID: 0413613 Publication Model: Print Cited Medium: Print ISSN: 0031-6903 (Print)

Record details

×
  • 1-10 of  11 results for ""ALZHEIMER'S patients""